|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000171431 |
Summary for KRT20 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000171431 | Gene symbol | KRT20 |
| Gene name | keratin 20 | |
| HGNC | 20412 | |
| Entrez ID | 54474 | |
| Gene type | protein_coding | |
| Synonyms | KRT20|CK20|K20|MGC35423 | |
| UniProtAcc | P35900 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for KRT20 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRT20 | 6.31e+01 | 2.42e+00 | 3.01e-01 | 8.05e+00 | 8.19e-16 | 3.17e-13 | LUAD |
| KRT20 | 8.45e+01 | -2.63e+00 | 4.50e-01 | -5.86e+00 | 4.66e-09 | 2.16e-07 | KIRP |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRT20 | 4.00e+01 | 4.11e+00 | 5.35e-01 | 7.69e+00 | 1.44e-14 | 4.95e-14 | LUSC |
| KRT20 | 9.18e+03 | -2.56e+00 | 6.42e-01 | -3.98e+00 | 6.92e-05 | 2.61e-04 | STAD |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRT20 | 2.24e+01 | 3.81e+00 | 7.88e-01 | 4.84e+00 | 1.31e-06 | 4.68e-06 | KIRC |
| KRT20 | 1.09e+01 | 3.40e+00 | 4.01e-01 | 8.50e+00 | 1.90e-17 | 5.77e-17 | BRCA |
| KRT20 | 1.22e+04 | -2.60e+00 | 4.83e-01 | -5.39e+00 | 7.09e-08 | 8.59e-07 | READ |
Top |
Sex-biased somatic mutation for KRT20 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for KRT20 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg00091693 | chr17:40885350 | CGI:chr17:40863135-40863849 | promoter | 6.83e-01 | 4.92e-01 | 2.87e+00 | 4.10e-03 | 1.88e-02 | 1.90e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg00091693 | chr17:40885350 | CGI:chr17:40863135-40863849 | promoter | 5.84e-01 | 8.03e-01 | -3.74e+00 | 1.84e-04 | 9.29e-04 | -2.20e-01 |
| COAD | cg25124433 | chr17:40884858 | CGI:chr17:40863135-40863849 | promoter,exon,CDS,gene body | 4.68e-01 | 6.67e-01 | -3.32e+00 | 9.02e-04 | 2.06e-03 | -1.99e-01 |
| COAD | cg23901700 | chr17:40884867 | CGI:chr17:40863135-40863849 | promoter,exon,CDS,gene body | 4.37e-01 | 6.19e-01 | -3.24e+00 | 1.19e-03 | 2.59e-03 | -1.82e-01 |
| BLCA | cg13602343 | chr17:40886188 | CGI:chr17:40863135-40863849 | promoter | 5.87e-01 | 4.59e-01 | 2.47e+00 | 1.34e-02 | 1.79e-02 | 1.28e-01 |
| LIHC | cg25124433 | chr17:40884858 | CGI:chr17:40863135-40863849 | promoter,exon,CDS,gene body | 6.85e-01 | 9.22e-01 | -4.48e+00 | 7.50e-06 | 2.13e-05 | -2.37e-01 |
| LIHC | cg23901700 | chr17:40884867 | CGI:chr17:40863135-40863849 | promoter,exon,CDS,gene body | 6.93e-01 | 9.21e-01 | -3.79e+00 | 1.50e-04 | 2.95e-04 | -2.28e-01 |
| LIHC | cg19449377 | chr17:40884947 | CGI:chr17:40863135-40863849 | promoter,exon,CDS,gene body | 5.62e-01 | 8.02e-01 | -3.34e+00 | 8.35e-04 | 1.35e-03 | -2.39e-01 |
| LIHC | cg00091693 | chr17:40885350 | CGI:chr17:40863135-40863849 | promoter | 4.72e-01 | 6.55e-01 | -3.19e+00 | 1.43e-03 | 2.18e-03 | -1.84e-01 |
| LIHC | cg13602343 | chr17:40886188 | CGI:chr17:40863135-40863849 | promoter | 4.94e-01 | 6.57e-01 | -2.94e+00 | 3.28e-03 | 4.54e-03 | -1.63e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg00091693 | chr17:40885350 | CGI:chr17:40863135-40863849 | promoter | 6.83e-01 | 8.24e-01 | -8.76e+00 | 1.93e-18 | 9.18e-18 | -1.41e-01 |
| LUAD | cg13602343 | chr17:40886188 | CGI:chr17:40863135-40863849 | promoter | 7.86e-01 | 6.74e-01 | 3.41e+00 | 6.47e-04 | 2.41e-03 | 1.12e-01 |
| BLCA | cg19114576 | chr17:40885014 | CGI:chr17:40863135-40863849 | promoter,exon,CDS,gene body | 5.81e-01 | 8.30e-01 | -2.44e+00 | 1.47e-02 | 2.22e-02 | -2.49e-01 |
Top |
Exon skipping events with PSI in TCGA for KRT20 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for KRT20 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for KRT20 |
| TFs related to KRT20. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | ZNF320 | KRT20 | 3.88e+00 | 9.84e-01 | 2.50e+00 | 1.77e-03 | Male-biased |
| CHOL | ZNF563 | KRT20 | 4.11e+00 | 9.86e-01 | 2.92e+00 | 4.00e-03 | Male-biased |
| CHOL | ZNF780A | KRT20 | 4.01e+00 | 9.88e-01 | 2.54e+00 | 1.21e-03 | Male-biased |
| CHOL | ZNF860 | KRT20 | 4.00e+00 | 9.85e-01 | 2.80e+00 | 3.89e-03 | Male-biased |
| ESCA | HOXC10 | KRT20 | 4.58e+00 | 9.84e-01 | 3.87e+00 | 1.06e-02 | Male-biased |
| ESCA | IRF2 | KRT20 | 4.44e+00 | 9.86e-01 | 3.68e+00 | 7.55e-03 | Male-biased |
| ESCA | LMX1B | KRT20 | 4.50e+00 | 9.91e-01 | 3.62e+00 | 3.97e-03 | Male-biased |
| ESCA | POU3F3 | KRT20 | 4.41e+00 | 9.84e-01 | 3.68e+00 | 9.28e-03 | Male-biased |
| ESCA | ZNF274 | KRT20 | 4.06e+00 | 9.83e-01 | 3.24e+00 | 5.56e-03 | Male-biased |
| PAAD | HOXC10 | KRT20 | 4.25e+00 | 3.79e-03 | 5.25e+00 | 9.94e-01 | Female-biased |
| PAAD | IRF2 | KRT20 | 4.14e+00 | 6.63e-03 | 5.03e+00 | 9.91e-01 | Female-biased |
| PAAD | LMX1B | KRT20 | 4.09e+00 | 2.50e-03 | 5.17e+00 | 9.95e-01 | Female-biased |
| PAAD | MYNN | KRT20 | 3.95e+00 | 2.47e-03 | 5.04e+00 | 9.95e-01 | Female-biased |
| PAAD | ONECUT3 | KRT20 | 4.80e+00 | 8.49e-03 | 5.64e+00 | 9.90e-01 | Female-biased |
| PAAD | POU3F3 | KRT20 | 4.11e+00 | 1.95e-03 | 5.23e+00 | 9.96e-01 | Female-biased |
| PAAD | STAT2 | KRT20 | 2.78e+00 | 1.95e-03 | 3.89e+00 | 9.82e-01 | Female-biased |
| PAAD | STAT6 | KRT20 | 3.51e+00 | 3.61e-03 | 4.51e+00 | 9.90e-01 | Female-biased |
| PAAD | ZFP69 | KRT20 | 3.94e+00 | 9.18e-03 | 4.76e+00 | 9.87e-01 | Female-biased |
| PAAD | ZKSCAN2 | KRT20 | 4.21e+00 | 4.97e-03 | 5.16e+00 | 9.93e-01 | Female-biased |
| PAAD | ZNF274 | KRT20 | 3.53e+00 | 3.22e-03 | 4.56e+00 | 9.91e-01 | Female-biased |
| PAAD | ZNF35 | KRT20 | 4.01e+00 | 3.69e-03 | 5.02e+00 | 9.94e-01 | Female-biased |
| PAAD | ZNF528 | KRT20 | 3.87e+00 | 1.34e-02 | 4.61e+00 | 9.81e-01 | Female-biased |
| KRT20 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for KRT20 |
| RBPs related to ES in KRT20. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| KRT20 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4794125 | chr17:50287058:C:T | - | 0.318993672173009 | 0.00748469737772937 | KIRP | Female-baised eQTL |
| rs35060088 | chr17:40875774:C:T | - | 0.164535452148611 | 0.0372045685737383 | KIRP | Female-baised eQTL |
| rs2285820 | chr17:40877159:A:C | gene | 0.164535452148611 | 0.0372045685737383 | KIRP | Female-baised eQTL |
| rs1894409 | chr17:40877215:T:C | gene | 0.164535452148611 | 0.0372045685737383 | KIRP | Female-baised eQTL |
| rs17546654 | chr17:44917727:G:A | - | 0.160006186497464 | 0.00130594264381901 | STAD | Female-baised eQTL |
| rs76771822 | chr17:44930751:C:T | - | 0.165652516584905 | 0.00338193535773721 | STAD | Female-baised eQTL |
| rs112908447 | chr17:44959149:T:C | - | 0.166526093605096 | 0.00364425233622257 | STAD | Female-baised eQTL |
| rs112451491 | chr17:44950167:C:T | - | 0.164813930747961 | 0.00366599821174831 | STAD | Female-baised eQTL |
| rs8067539 | chr17:44951688:G:A | - | 0.164813930747961 | 0.00366599821174831 | STAD | Female-baised eQTL |
| rs75498163 | chr17:44955189:C:T | - | 0.164813930747961 | 0.00366599821174831 | STAD | Female-baised eQTL |
| rs76233903 | chr17:44956179:C:G | - | 0.164813930747961 | 0.00366599821174831 | STAD | Female-baised eQTL |
| rs76238604 | chr17:44922334:C:T | - | 0.155794604422851 | 0.00748615633091701 | STAD | Female-baised eQTL |
| rs74854014 | chr17:44921474:C:A | - | 0.159737557745857 | 0.0144969308335082 | STAD | Female-baised eQTL |
| rs76566528 | chr17:44914884:G:A | - | 0.143996703375021 | 0.0198013568758739 | STAD | Female-baised eQTL |
| rs111305569 | chr17:44925336:A:G | - | 0.129728950966311 | 0.0249931153419102 | STAD | Female-baised eQTL |
| rs7218001 | chr17:44931537:C:A | - | 0.129595595311836 | 0.0259032097618855 | STAD | Female-baised eQTL |
| rs755547 | chr17:44934540:G:A | - | 0.128010156392817 | 0.0336660355821822 | STAD | Female-baised eQTL |
| rs7211025 | chr17:36670243:C:A | - | 0.263845878134445 | 0.0270995710177468 | BLCA | Female-baised eQTL |
| rs117301014 | chr17:48272709:C:T | - | 0.237670452570949 | 0.0402138641016365 | BLCA | Female-baised eQTL |
| rs118107232 | chr17:48266069:A:G | - | 0.23664412776022 | 0.0428199274275775 | BLCA | Female-baised eQTL |
| rs6503492 | chr17:44201038:T:A | - | -0.0594660364653477 | 0.0107574430208504 | LUAD | Female-baised eQTL |
| rs7218599 | chr17:44170978:A:T | - | -0.0571102563883671 | 0.0147457826453366 | LUAD | Female-baised eQTL |
| rs757430 | chr17:44190906:C:T | - | -0.0571061370120298 | 0.0147569713637604 | LUAD | Female-baised eQTL |
| rs9303601 | chr17:44201473:A:G | - | -0.0570892803848898 | 0.0149612951707596 | LUAD | Female-baised eQTL |
| rs8073555 | chr17:44188856:G:C | - | -0.0559908120237675 | 0.0173287588960043 | LUAD | Female-baised eQTL |
| rs117745330 | chr17:49217646:C:A | - | 0.0546228433551113 | 0.0326961937044644 | LUAD | Female-baised eQTL |
| rs143612763 | chr17:36049554:C:T | - | 0.0595520608477659 | 0.0336649099978185 | LUAD | Female-baised eQTL |
| rs28547426 | chr17:36055123:G:T | - | 0.0579769037836546 | 0.0400042827166175 | LUAD | Female-baised eQTL |
| rs315435 | chr17:31655119:A:G | - | -0.0499739762407112 | 0.0492663234188322 | LUAD | Female-baised eQTL |
| rs7218136 | chr17:41313951:C:T | - | 0.0909552630418598 | 0.00427922051966395 | COAD | Female-baised eQTL |
| rs8073074 | chr17:37146025:A:G | - | -0.0848017084669548 | 0.00855361963112739 | COAD | Female-baised eQTL |
| rs7215793 | chr17:37136768:T:C | - | -0.0847111598819633 | 0.00858954816063461 | COAD | Female-baised eQTL |
| rs7211430 | chr17:37142873:G:T | - | -0.0808649165989141 | 0.0147420220041951 | COAD | Female-baised eQTL |
| rs111806841 | chr17:41311659:C:T | - | 0.0851116900302585 | 0.0197337349265137 | COAD | Female-baised eQTL |
| rs2229416 | chr17:37252940:C:T | - | 0.0862828733170578 | 0.0218528218611951 | COAD | Female-baised eQTL |
| rs2680395 | chr17:37268683:A:G | - | 0.0862828733170578 | 0.0218528218611951 | COAD | Female-baised eQTL |
| rs2542658 | chr17:37269165:A:C | - | 0.0862828733170578 | 0.0218528218611951 | COAD | Female-baised eQTL |
| rs2542656 | chr17:37268341:T:C | - | 0.0860951050783276 | 0.0226235238230564 | COAD | Female-baised eQTL |
| rs2680391 | chr17:37250525:C:T | - | 0.0882395971573047 | 0.0239188755715679 | COAD | Female-baised eQTL |
| rs2542654 | chr17:37254782:G:A | - | 0.0882395971573047 | 0.0239188755715679 | COAD | Female-baised eQTL |
| rs2071562 | chr17:41465534:T:C | - | 0.0871319963052415 | 0.0256757360006924 | COAD | Female-baised eQTL |
| rs6503624 | chr17:41348341:G:C | - | 0.0711597431845358 | 0.0281087321658586 | COAD | Female-baised eQTL |
| rs59538284 | chr17:41416461:A:C | - | 0.0851981229739847 | 0.0286579990541762 | COAD | Female-baised eQTL |
| rs16966660 | chr17:41309702:T:G | - | 0.0792955976997827 | 0.0341099895601137 | COAD | Female-baised eQTL |
| rs62065180 | chr17:41461689:T:C | - | 0.0870403697128721 | 0.0349377809865661 | COAD | Female-baised eQTL |
| rs2074288 | chr17:41307478:A:C | - | 0.0812245697179893 | 0.0351352912493643 | COAD | Female-baised eQTL |
| rs76198249 | chr17:37166497:C:G | - | 0.0825134874157993 | 0.0353342408260578 | COAD | Female-baised eQTL |
| rs74757919 | chr17:37167038:G:A | - | 0.0825134874157993 | 0.0353342408260578 | COAD | Female-baised eQTL |
| rs12889 | chr17:44011485:G:A | - | -0.12840263340078 | 0.0362653673839993 | COAD | Female-baised eQTL |
| rs77166431 | chr17:37164673:A:C | - | 0.0823375053398138 | 0.0363553625424426 | COAD | Female-baised eQTL |
| rs315474 | chr17:31666463:A:T | - | -0.0982112811372844 | 0.0387014828843926 | COAD | Female-baised eQTL |
| rs79762688 | chr17:37156036:A:G | - | 0.0814592337805324 | 0.0391429434652282 | COAD | Female-baised eQTL |
| rs12601087 | chr17:37156305:C:T | - | 0.0814592337805324 | 0.0391429434652282 | COAD | Female-baised eQTL |
| rs12449556 | chr17:41298249:G:C | - | 0.0786580054840901 | 0.0402349648526892 | COAD | Female-baised eQTL |
| rs12449472 | chr17:41288155:T:C | - | 0.0784153854357133 | 0.0407823943115959 | COAD | Female-baised eQTL |
| rs9890510 | chr17:48647787:G:A | - | 0.132148063576146 | 0.0425838430981728 | COAD | Female-baised eQTL |
| rs1266184 | chr17:37096350:G:C | - | 0.0752828135669005 | 0.0451807481403668 | COAD | Female-baised eQTL |
| rs2631292 | chr17:44056030:A:G | - | -0.129621585339694 | 0.0451834520704291 | COAD | Female-baised eQTL |
| rs664610 | chr17:44056449:T:C | - | -0.129621585339694 | 0.0451834520704291 | COAD | Female-baised eQTL |
| rs4793073 | chr17:44057727:A:C | - | -0.129621585339694 | 0.0451834520704291 | COAD | Female-baised eQTL |
| rs4793074 | chr17:44057728:T:C | - | -0.129621585339694 | 0.0451834520704291 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs112921991 | chr17:48647106:G:C | - | 0.138170608831175 | 0.00989763486814435 | READ | Male-baised eQTL |
| rs3744774 | chr17:48635352:C:T | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs881012 | chr17:48636656:C:G | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs76839444 | chr17:48637429:T:C | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs11079831 | chr17:48638043:A:G | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs2303489 | chr17:48639296:C:T | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs80037076 | chr17:48640865:G:A | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs113528296 | chr17:48641761:C:T | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs16942777 | chr17:48642328:G:A | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs112868900 | chr17:48642504:G:A | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs890434 | chr17:48642869:G:C | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs890433 | chr17:48643126:C:T | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs16942817 | chr17:48644044:A:G | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs76861848 | chr17:48645965:A:C | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs75683003 | chr17:48647872:C:G | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs79294365 | chr17:48647943:C:T | - | 0.130478407913896 | 0.0179262309797187 | READ | Male-baised eQTL |
| rs112409771 | chr17:48625637:C:G | - | 0.128439085368056 | 0.0237131673021354 | READ | Male-baised eQTL |
| rs76457348 | chr17:48628433:C:T | - | 0.128439085368056 | 0.0237131673021354 | READ | Male-baised eQTL |
| rs34027279 | chr17:34408671:G:C | - | 0.122215262749243 | 0.0266232913597395 | READ | Male-baised eQTL |
| rs111872077 | chr17:48651347:C:T | - | 0.123334792901129 | 0.0304096134852003 | READ | Male-baised eQTL |
| rs112269042 | chr17:48661004:G:A | - | 0.123334792901129 | 0.0304096134852003 | READ | Male-baised eQTL |
| rs76310719 | chr17:34395097:T:A | - | 0.116824162982445 | 0.0370022086223515 | READ | Male-baised eQTL |
| rs3136675 | chr17:34355729:C:T | - | 0.116039597767099 | 0.0406547046922489 | READ | Male-baised eQTL |
| rs7207490 | chr17:33477551:A:G | - | 0.044230160141708 | 0.0274377508811083 | BLCA | Male-baised eQTL |
| rs9903658 | chr17:33729207:A:G | - | 0.0510020857910781 | 0.0133420400169612 | LUAD | Male-baised eQTL |
| rs9916500 | chr17:33727911:C:T | - | 0.0461439290085029 | 0.0301510153274005 | LUAD | Male-baised eQTL |
| rs390146 | chr17:41173065:A:T | - | -0.0606225561890942 | 0.0429836853540309 | LUAD | Male-baised eQTL |
| rs375880 | chr17:41173079:T:C | - | -0.0606225561890942 | 0.0429836853540309 | LUAD | Male-baised eQTL |
| rs390194 | chr17:41173106:G:T | - | -0.0606225561890942 | 0.0429836853540309 | LUAD | Male-baised eQTL |
| rs396310 | chr17:41173115:G:T | - | -0.0606225561890942 | 0.0429836853540309 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000171431 |
| CpG Site: cg23901700 | |
| Position to Gene: gene,exon,CDS,promoter | |
| Male Effect: -0.497926545919314 | |
| Female Effect: - | |
 | Gene ID: ENSG00000171431 |
| CpG Site: cg19449377 | |
| Position to Gene: gene,exon,CDS,promoter | |
| Male Effect: -0.497926545919314 | |
| Female Effect: - | |
 | Gene ID: ENSG00000171431 |
| CpG Site: cg00091693 | |
| Position to Gene: promoter | |
| Male Effect: -0.497926545919314 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg23901700 | chr17:40884867 | gene,exon,CDS,promoter | -0.497926545919314 | 4.82827873477878e-108 | -0.9502453007719073 | 6.4008483883596336e-114 | LUAD |
| cg19449377 | chr17:40884947 | gene,exon,CDS,promoter | -0.497926545919314 | 4.82827873477878e-108 | -0.9502453007719073 | 6.4008483883596336e-114 | LUAD |
| cg00091693 | chr17:40885350 | promoter | -0.497926545919314 | 4.82827873477878e-108 | -0.9502453007719073 | 6.4008483883596336e-114 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of KRT20 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000171431 | KRT20 | C0001418 | Adenocarcinoma | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0007528 | Cecal Neoplasms | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0153437 | Malignant neoplasm of cecum | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
| ENSG00000171431 | KRT20 | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
